Close Menu

NEW YORK (GenomeWeb) – NanoString Technologies reported after the close of the market Thursday that its total revenues for the fourth quarter of 2018 were down about 15 percent year over year, while its product and services revenue grew 12 percent.

For the three months ended Dec. 31, 2018, total revenues dropped to $30.0 million from $35.2 million in Q4 2017, beating the average Wall Street estimate of $29.4 million.

The firm said it took in $23.6 million in product and service revenue in the quarter, a 12 percent increase from $21.0 million in Q4 2017.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jun
13

Ribosomal ribonucleic acid (rRNA) accounts for up to 99 percent of the total RNA depending on the cell type. 

Jun
18
Sponsored by
ArcherDX

This webinar will discuss background and clinical genomics of NTRK fusion detection in cancer. NTRK fusions are the focus of new therapeutic options, but clonal and subclonal lesions are notoriously difficult to detect. 

Jun
19

This webinar will discuss cell-free DNA prenatal screening in the era of genome-wide sequencing and factors influencing the clinical utility of expanded noninvasive prenatal testing (NIPT) menus.